Temat: "Netherlands" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: OXA-48-Producing Uropathogenic Escherichia coli Sequence Type 127, the Netherlands, 2015-2022.
Autorzy:: Mulder M
Notermans DW
Wielders CCH
Bos J
Witteveen S
Ganesh VA
Landman F
de Haan A
Schneeberger-van der Linden C
Hendrickx APA; Pokaż więcej
Corporate Authors:: Dutch CPE Surveillance Study Group1
Źródło:: Emerging infectious diseases [Emerg Infect Dis] 2023 Dec; Vol. 29 (12), pp. 2563-2565.
Typ publikacji:: Journal Article
MeSH Terms:: Escherichia coli Infections*/epidemiology
Uropathogenic Escherichia coli*/genetics
Urinary Tract Infections*/epidemiology
Humans ; Netherlands/epidemiology ; Anti-Bacterial Agents ; Virulence Factors/genetics ; beta-Lactamases/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Policies that Support and Hinder Families as Partners in Care during COVID-19 Pandemic: Comparative Policy Learning from England, British Columbia, and the Netherlands.
Autorzy:: Keefe JM; Nova Scotia Centre on Aging, Mount Saint Vincent University, Halifax, NS, Canada.
Krawchenko T; School of Public Administration, University of Victoria, Victoria, BC, Canada.; Pokaż więcej
Źródło:: Canadian journal on aging = La revue canadienne du vieillissement [Can J Aging] 2023 Dec; Vol. 42 (4), pp. 754-760. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*
Humans ; British Columbia ; Pandemics ; Netherlands ; Long-Term Care ; Policy

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: A 95% decline in estimated newly acquired HIV infections, Amsterdam, 2010 to 2022.
Corporate Authors:: HIV Transmission Elimination AMsterdam (H-TEAM) Initiative; The members of the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative are listed under Investigators.
Źródło:: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Oct; Vol. 28 (40).
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/diagnosis
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Humans ; Cities ; Netherlands/epidemiology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: Adolescents' hair cortisol concentrations during COVID-19: Evidence from two longitudinal studies in the Netherlands and the United States.
Autorzy:: Vacaru SV; Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Clinical Child and Family Studies & Amsterdam Public Health, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Parenteau AM; Department of Psychology, University of California, Davis, Davis, California, USA.; Center for Mind and Brain, University of California, Davis, Davis, California, USA.
Yi S; Department of Psychology, University of California, Davis, Davis, California, USA.; Center for Mind and Brain, University of California, Davis, Davis, California, USA.
Silvers JA; Department of Psychology, University of California, Los Angeles, Los Angeles, California, USA.
Hostinar CE; Department of Psychology, University of California, Davis, Davis, California, USA.; Center for Mind and Brain, University of California, Davis, Davis, California, USA.
de Weerth C; Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands.; Pokaż więcej
Źródło:: Developmental psychobiology [Dev Psychobiol] 2023 Dec; Vol. 65 (8), pp. e22438.
Typ publikacji:: Journal Article
MeSH Terms:: Hydrocortisone*/analysis
COVID-19*
Child ; Female ; Humans ; Adolescent ; United States/epidemiology ; Stress, Psychological ; Netherlands ; Pandemics ; Hair/chemistry ; Longitudinal Studies ; Hypothalamo-Hypophyseal System ; Pituitary-Adrenal System

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: Direct-to-patient digital diagnostics in primary care: Opportunities, challenges, and conditions necessary for responsible digital diagnostics.
Autorzy:: Villalobos-Quesada M; Department of Public Health and Primary Care, National eHealth Living Lab, Leiden University Medical Centre, Leiden, The Netherlands.
Ho K; Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; Cloud Innovation Centre for Community Health and Wellbeing, University of British Columbia, Vancouver, Canada.
Chavannes NH; Department of Public Health and Primary Care, National eHealth Living Lab, Leiden University Medical Centre, Leiden, The Netherlands.
Talboom-Kamp EP; Department of Public Health and Primary Care, National eHealth Living Lab, Leiden University Medical Centre, Leiden, The Netherlands.; Pokaż więcej
Źródło:: The European journal of general practice [Eur J Gen Pract] 2023 Dec; Vol. 29 (1), pp. 2273615. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:: Journal Article
MeSH Terms:: Health Personnel*
Primary Health Care*
Humans ; Qualitative Research ; Netherlands

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: Early qualitative and quantitative amplitude-integrated electroencephalogram and raw electroencephalogram for predicting long-term neurodevelopmental outcomes in extremely preterm infants in the Netherlands: a 10-year cohort study.
Autorzy:: Wang X; Department of Neonatology, University Medical Centre Utrecht, Utrecht, Netherlands.
Trabatti C; Pediatric and Neonatology Unit, Maggiore Hospital, ASST Crema, Crema, Italy.
Weeke L; Department of Neonatology, University Medical Centre Utrecht, Utrecht, Netherlands.
Dudink J; Department of Neonatology, University Medical Centre Utrecht, Utrecht, Netherlands; Wilhelmina Children's Hospital, and Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht, Netherlands.
Swanenburg de Veye H; Psychosocial Department, University Medical Centre Utrecht, Utrecht, Netherlands.
Eijsermans RMJC; Department of Neonatology, University Medical Centre Utrecht, Utrecht, Netherlands; Child Development and Exercise Centre, University Medical Centre Utrecht, Utrecht, Netherlands.
Koopman-Esseboom C; Department of Neonatology, University Medical Centre Utrecht, Utrecht, Netherlands.
Benders MJNL; Department of Neonatology, University Medical Centre Utrecht, Utrecht, Netherlands; Wilhelmina Children's Hospital, and Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht, Netherlands.
Tataranno ML; Department of Neonatology, University Medical Centre Utrecht, Utrecht, Netherlands; Wilhelmina Children's Hospital, and Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht, Netherlands. Electronic address: .; Pokaż więcej
Źródło:: The Lancet. Digital health [Lancet Digit Health] 2023 Dec; Vol. 5 (12), pp. e895-e904. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:: Journal Article
MeSH Terms:: Infant, Extremely Premature*
Electroencephalography*
Infant ; Child ; Humans ; Infant, Newborn ; Child, Preschool ; Cohort Studies ; Retrospective Studies ; Netherlands

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 7.

Tytuł:: External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Autorzy:: Wang Y; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Broeks A; Core Facility Molecular Pathology and Biobanking, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Giardiello D; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Eurac Research, Institute of Biomedicine, Epidemiology and Biostatistics, Bolzano, Italy.
Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Koop EA; Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, the Netherlands.
Opdam M; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands.
Sonke GS; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Stathonikos N; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Ter Hoeve ND; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
van der Wall E; Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, the Netherlands.
van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.
Vreuls W; Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, the Netherlands.
Linn SC; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Dackus GMHE; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: .
Schmidt MK; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: .; Pokaż więcej
Źródło:: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113401. Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Humans ; Female ; Adult ; Prognosis ; Chemotherapy, Adjuvant ; Registries ; Netherlands

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 8.

Tytuł:: Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study.
Autorzy:: Eijkelboom AH; Department of Health Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT Utrecht, the Netherlands. Electronic address: .
de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT Utrecht, the Netherlands.
Larsen M; Section for Breast Cancer Screening, Cancer Registry of Norway, P.O. Box 5313, 0304 Oslo, Norway.
Bijlsma MJ; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT Utrecht, the Netherlands; PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, P.O. Box 196, 9700 AD Groningen, the Netherlands.
Tjan-Heijnen VCG; Department of Medical Oncology, School for Oncology and Reproduction (GROW), Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.
van Gils CH; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands.
Broeders MJM; Department for Health Evidence, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands; Dutch Expert Centre for Screening, Wijchenseweg 101, 6538 SW, Nijmegen, the Netherlands.
Nygård JF; Department of Register Informatics, Cancer Registry Norway, P.O. Box 5313, 0304 Oslo, Norway.
Lobbes MBI; Department of Medical Imaging, Zuyderland Medical Center Sittard-Geleen, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, the Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands; School for Oncology and Reproduction (GROW), Maastricht University Medical Centre, Universiteitssingel 40, 6220 ER, Maastricht, the Netherlands.
Helsper CW; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, the Netherlands.
Pijnappel RM; Dutch Expert Centre for Screening, Wijchenseweg 101, 6538 SW, Nijmegen, the Netherlands; Department of Radiology, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.
Strobbe LJA; Department of Surgical Oncology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, the Netherlands.
Wesseling J; Divisions of Diagnostic Oncology and Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
Hofvind S; Section for Breast Cancer Screening, Cancer Registry of Norway, P.O. Box 5313, 0304 Oslo, Norway; Department of Health and Care Sciences, UiT The Arctic University of Norway, P.O. 6050, 9037 Tromsø, Norway.
Siesling S; Department of Health Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT Utrecht, the Netherlands.; Pokaż więcej
Corporate Authors:: NABON-COVID-19 Consortium & The COVID and Cancer Care-NL Consortium
Źródło:: Cancer epidemiology [Cancer Epidemiol] 2023 Dec; Vol. 87, pp. 102481. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
COVID-19*/epidemiology
COVID-19*/pathology
Female ; Humans ; Incidence ; Pandemics ; Netherlands/epidemiology ; Neoplasm Staging ; Mass Screening/methods ; Norway/epidemiology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 9.

Tytuł:: Current preconception care practice in the Netherlands - An evaluation study among birth care professionals.
Autorzy:: Scheele J; Research Center Innovations in Care, Rotterdam University of Applied Sciences, Rochussenstraat 198, 3015 EK Rotterdam, the Netherlands. Electronic address: .
Smith SM; Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, Rotterdam the Netherlands.
Wahab RJ; The Generation R Study Group, Erasmus MC, University Medical Center, 3000 CA Rotterdam, the Netherlands; Department of Pediatrics, Erasmus MC, University Medical Center, 3000 CA Rotterdam, the Netherlands.
Bais B; Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, Rotterdam the Netherlands.
Steegers-Theunissen RPM; Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, Rotterdam the Netherlands.
Gaillard R; The Generation R Study Group, Erasmus MC, University Medical Center, 3000 CA Rotterdam, the Netherlands; Department of Pediatrics, Erasmus MC, University Medical Center, 3000 CA Rotterdam, the Netherlands.
Harmsen van der Vliet-Torij HW; Research Center Innovations in Care, Rotterdam University of Applied Sciences, Rochussenstraat 198, 3015 EK Rotterdam, the Netherlands; Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, Rotterdam the Netherlands.; Pokaż więcej
Źródło:: Midwifery [Midwifery] 2023 Dec; Vol. 127, pp. 103855. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:: Journal Article
MeSH Terms:: Preconception Care*/methods
Midwifery*
Pregnancy ; Female ; Humans ; Netherlands ; Cross-Sectional Studies ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 10.

Tytuł:: The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands.
Autorzy:: Slingerland P; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.
van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands. .
Lieber T; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.
van Balveren L; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.
Duijster JW; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.; Pokaż więcej
Źródło:: Drug safety [Drug Saf] 2023 Dec; Vol. 46 (12), pp. 1323-1334. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*/adverse effects
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/etiology
Male ; Female ; Humans ; Incidence ; Netherlands/epidemiology ; Seasons ; Vaccination/adverse effects ; Adverse Drug Reaction Reporting Systems

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 11.

Tytuł:: High number of HPAI H5 virus infections and antibodies in wild carnivores in the Netherlands, 2020-2022.
Autorzy:: Chestakova IV; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
van der Linden A; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
Bellido Martin B; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
Caliendo V; Dutch Wildlife Health Centre, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Vuong O; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
Thewessen S; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
Hartung T; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
Bestebroer T; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
Dekker J; Jasja Dekker Dierecologie B.V., Arnhem, The Netherlands.
Jonge Poerink B; Ecosensys, Zuurdijk, The Netherlands.
Gröne A; Dutch Wildlife Health Centre, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.; Division of Pathology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Koopmans M; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
Fouchier R; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
van den Brand JMA; Dutch Wildlife Health Centre, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.; Division of Pathology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Sikkema RS; Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.; Pokaż więcej
Źródło:: Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (2), pp. 2270068. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza in Birds*
Humans ; Animals ; Netherlands ; Animals, Wild ; Birds ; Disease Outbreaks/veterinary ; Antibodies ; Phylogeny ; Mammals

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 12.

Tytuł:: Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in The Netherlands (TRAPeze Netherlands study).
Autorzy:: Gerard Jansen AJ; Department of Haematology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
McDonald V; Department of Clinical Haematology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Newland A; Academic Haematology Unit, Blizzard Institute, Barts & The London School of Medicine & Dentistry, Queen Mary Institute of London, London, UK.
Morgan M; ITP Support Association, Bolnhurst, UK.
Bastiaanse M; Sobi, Amsterdam, Netherlands.
Wilson K; Sobi, Stockholm, Sweden.
Eriksson D; Sobi, Stockholm, Sweden.
Geldman E; Wickenstones Ltd, Abingdon, UK.
Daykin-Pont O; Wickenstones Ltd, Abingdon, UK.
Prince S; Wickenstones Ltd, Abingdon, UK.
Zwaginga JJ; Department of Haematology, Leiden University Medical Centre, Leiden, Netherlands.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2267942. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:: Journal Article
MeSH Terms:: Purpura, Thrombocytopenic, Idiopathic*/drug therapy
Thrombocytopenia*
Female ; Humans ; Male ; Middle Aged ; Benzoates/therapeutic use ; Hydrazines/therapeutic use ; Netherlands ; Patient Preference ; Quality of Life ; Receptors, Fc/therapeutic use ; Recombinant Fusion Proteins/therapeutic use ; Thrombopoietin/metabolism ; Thrombopoietin/therapeutic use ; Young Adult ; Adult ; Aged ; Aged, 80 and over

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 13.

Tytuł:: Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.
Autorzy:: Gauffin O; Uppsala Monitoring Centre, Uppsala, Sweden.
Brand JS; Uppsala Monitoring Centre, Uppsala, Sweden. .
Vidlin SH; Uppsala Monitoring Centre, Uppsala, Sweden.
Sartori D; Uppsala Monitoring Centre, Uppsala, Sweden.
Asikainen S; BCB Medical Ltd, Turku, Finland.
Català M; Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Chalabi E; Heliant Ltd, Belgrade, Serbia.
Dedman D; Clinical Practice Research Datalink (CPRD), The Medicines and Healthcare Products Regulatory Agency, London, UK.
Danilovic A; CHC Zvezdara, Belgrade, Serbia.
Duarte-Salles T; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
García Morales MT; Instituto de Investigación Sanitaria Hospital 12 de Octubre, CIBER de Epidemiología y Salud Pública, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
Hiltunen S; BCB Medical Ltd, Espoo, Finland.
Jödicke AM; Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Lazarevic M; Clinic for cardiac and transplant surgery, University Clinical Center Nis, Nis, Serbia.
Mayer MA; Hospital del Mar Medical Research Institute, Parc de Salut Mar, Barcelona, Spain.
Miladinovic J; Clinic for infectious diseases, University Clinical Center Nis, University Clinical Center Nis, Nis, Serbia.
Mitchell J; Uppsala Monitoring Centre, Uppsala, Sweden.
Pistillo A; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Ramírez-Anguita JM; Hospital del Mar Medical Research Institute, Parc de Salut Mar, Barcelona, Spain.
Reyes C; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Rudolph A; Uppsala Monitoring Centre, Uppsala, Sweden.
Sandberg L; Uppsala Monitoring Centre, Uppsala, Sweden.
Savage R; Uppsala Monitoring Centre, Uppsala, Sweden.; Department of General Practice, University of Otago, Christchurch, New Zealand.
Schuemie M; Epidemiology Department, Johnson & Johnson, Titusville, NJ, USA.; Department of Biostatistics, UCLA, Los Angeles, CA, USA.
Spasic D; Clinic for cardiac and transplant surgery, University Clinical Center Nis, Nis, Serbia.
Trinh NTH; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
Veljkovic N; Heliant Ltd, Belgrade, Serbia.; Vinca Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Vujovic A; Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
de Wilde M; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Zekarias A; Uppsala Monitoring Centre, Uppsala, Sweden.
Rijnbeek P; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Ryan P; Epidemiology Department, Johnson & Johnson, Titusville, NJ, USA.; Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA.
Prieto-Alhambra D; Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Norén GN; Uppsala Monitoring Centre, Uppsala, Sweden.; Pokaż więcej
Źródło:: Drug safety [Drug Saf] 2023 Dec; Vol. 46 (12), pp. 1335-1352. Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:: Journal Article
MeSH Terms:: Pharmacovigilance*
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Humans ; Adverse Drug Reaction Reporting Systems ; Databases, Factual ; Netherlands

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: Stabilisation and resuscitation with intact cord circulation is feasible using a wide variety of approaches; a scoping review.
Autorzy:: Alikhani VS; Department of Pediatrics, Institution of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Department of Pediatrics, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
Thies-Lagergren L; Lund University, Lund, Sweden.
Svedenkrans J; Department of Clinical Sciences Lund, Pediatrics/Neonatology, Lund University, Lund, Sweden.; Division of Pediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.; Department of Neonatology, Karolinska University Hospital, Stockholm, Sweden.
Elfvin A; Department of Pediatrics, Institution of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Department of Pediatrics, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
Bolk J; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.; Sachs' Children and Youth Hospital, Stockholm, Sweden.
Andersson O; Department of Clinical Sciences Lund, Pediatrics/Neonatology, Lund University, Lund, Sweden.; Department of Neonatology, Skåne University Hospital, Malmö, Sweden.; Pokaż więcej
Źródło:: Acta paediatrica (Oslo, Norway : 1992) [Acta Paediatr] 2023 Dec; Vol. 112 (12), pp. 2468-2477. Date of Electronic Publication: 2023 Sep 28.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Cesarean Section*
Resuscitation*
Infant, Newborn ; Pregnancy ; Humans ; Female ; Netherlands ; United Kingdom ; Australia

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 15.

Tytuł:: Care Pathway Analysis to Inform the Earliest Stages of Technology Development: Scoping Oncological Indications in Need of Innovation.
Autorzy:: Scholte M; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Medical Imaging, Nijmegen, The Netherlands; Maastricht University Medical Centre+, Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht, The Netherlands. Electronic address: .
Heidkamp J; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Medical Imaging, Nijmegen, The Netherlands.
Hannink G; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Medical Imaging, Nijmegen, The Netherlands.
Merkx MAWT; Department of Research and Development, Netherlands Comprehensive Cancer Organization (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands; Dutch Rare Cancer Platform, The Netherlands; IQ Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands.
Grutters JPC; Radboud University Medical Center, Radboud Institute for Health Sciences, Department for Health Evidence, Nijmegen, The Netherlands.
Rovers MM; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Medical Imaging, Nijmegen, The Netherlands.; Pokaż więcej
Źródło:: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2023 Dec; Vol. 26 (12), pp. 1744-1753. Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:: Journal Article
MeSH Terms:: Critical Pathways*
Glioblastoma*
Male ; Humans ; Quality of Life ; Technology ; Netherlands

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 16.

Tytuł:: An updated evaluation of the implementation of the sigmoid take-off landmark 1 year after the official introduction in the Netherlands.
Autorzy:: Hazen SJA; Department of Surgery, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, De Boelelaan 1117, P.O. Box 7057, 1007 MB, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Sluckin TC; Department of Surgery, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, De Boelelaan 1117, P.O. Box 7057, 1007 MB, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Horsthuis K; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Radiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Lambregts DMJ; Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Beets-Tan RGH; Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; GROW School of Oncology and Developmental Biology, University of Maastricht, Maastricht, The Netherlands.
Tanis PJ; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Surgery, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Erasmus Medical Center, Surgical Oncology and Gastrointestinal Surgery, Rotterdam, The Netherlands.
Kusters M; Department of Surgery, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, De Boelelaan 1117, P.O. Box 7057, 1007 MB, Amsterdam, the Netherlands. .; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, The Netherlands. .; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands. .; Pokaż więcej
Corporate Authors:: Dutch Sigmoid Take-off Research Group
Źródło:: Techniques in coloproctology [Tech Coloproctol] 2023 Dec; Vol. 27 (12), pp. 1243-1250. Date of Electronic Publication: 2023 May 15.
Typ publikacji:: Journal Article
MeSH Terms:: Colon, Sigmoid*
Rectal Neoplasms*/diagnostic imaging
Rectal Neoplasms*/surgery
Rectal Neoplasms*/pathology
Humans ; Netherlands

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 17.

Tytuł:: Community midwives' perspectives on perinatal care for asylum seekers and refugees in the Netherlands: A survey study.
Autorzy:: Verschuuren AEH; Department of Health Sciences, Global Health Unit, University Medical Center Groningen & University of Groningen, Groningen, the Netherlands.
Tankink JB; Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Franx A; Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, The Netherlands.
van der Lans PJA; Department of Obstetrics and Gynecology, Hospital Twente ZGT/MST, Enschede, The Netherlands.
Erwich JJHM; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Jong EIF; Department of General Practice & Elderly Care Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Midwifery Academy Amsterdam Groningen, Groningen, the Netherlands.
de Graaf JP; Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Pokaż więcej
Źródło:: Birth (Berkeley, Calif.) [Birth] 2023 Dec; Vol. 50 (4), pp. 815-826. Date of Electronic Publication: 2023 Jun 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Refugees*/psychology
Midwifery*
Humans ; Female ; Pregnancy ; Infant, Newborn ; Child ; Perinatal Care ; Netherlands ; Cross-Sectional Studies ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 18.

Tytuł:: The impact of a summative national prescribing assessment and curriculum type on the development of the prescribing competence of junior doctors.
Autorzy:: Donker EM; Unit Pharmacotherapy, Department of Internal Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands. .; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, The Netherlands. .
Osmani H; Unit Pharmacotherapy, Department of Internal Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.
Brinkman DJ; Unit Pharmacotherapy, Department of Internal Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, The Netherlands.
van Rosse F; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Janssen B; Department of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands.
Knol W; Department of Geriatric Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Dumont G; Department of Hospital Pharmacy and Clinical Pharmacology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
Jorens PG; Department Pharmacotherapy, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.
Dupont A; Department of Clinical Pharmacology, Free University of Brussels (VUB), Brussels, Belgium.
Christiaens T; Clinical Pharmacology, Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium.
van Smeden J; Department of Education, Centre for Human Drug Research, Leiden, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
de Waard-Siebinga I; Department Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
Peeters LEJ; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Goorden R; Radboud University Medical Center, Nijmegen, The Netherlands.
Hessel M; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Lissenberg-Witte BI; Department of Epidemiology and Data Science, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands.
Richir MC; Unit Pharmacotherapy, Department of Internal Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, The Netherlands.; Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
van Agtmael MA; Unit Pharmacotherapy, Department of Internal Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, The Netherlands.
Kramers C; Pharmacology-Toxicology and Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Tichelaar J; Unit Pharmacotherapy, Department of Internal Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.; Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, The Netherlands.; Pokaż więcej
Corporate Authors:: Education committee of the Dutch Society for Clinical Pharmacology and Biopharmacy
Źródło:: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2023 Dec; Vol. 79 (12), pp. 1613-1621. Date of Electronic Publication: 2023 Sep 22.
Typ publikacji:: Journal Article
MeSH Terms:: Curriculum*
Education, Medical*
Humans ; Longitudinal Studies ; Netherlands ; Medical Staff, Hospital/education ; Clinical Competence

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 19.

Tytuł:: Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands.
Autorzy:: Quist SW; Asc Academics, Groningen, The Netherlands. .
Postma AJ; Asc Academics, Groningen, The Netherlands.
Myrén KJ; Alexion, AstraZeneca Rare Disease, Stockholm, Sweden.
de Jong LA; Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands.
Postma MJ; Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands.; Department of Economics, Econometrics and Finance, University of Groningen, Groningen, The Netherlands.; Pokaż więcej
Źródło:: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2023 Dec; Vol. 24 (9), pp. 1455-1472. Date of Electronic Publication: 2023 Jan 12.
Typ publikacji:: Journal Article
MeSH Terms:: Hemoglobinuria, Paroxysmal*/drug therapy
Adult ; Humans ; Cost-Benefit Analysis ; Quality of Life ; Netherlands

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 20.

Tytuł:: Economic evaluation of pharmacy services: a systematic review of the literature (2016-2020).
Autorzy:: Phimarn W; Social Pharmacy Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.
Saramunee K; Social Pharmacy Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand. .
Leelathanalerk A; Health Services and Pharmacy Practice Research and Innovation Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.; Clinical Trials and Evidence-Based Syntheses Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.
Srimongkon P; Health Services and Pharmacy Practice Research and Innovation Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.; Clinical Trials and Evidence-Based Syntheses Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.
Chanasopon S; Health Services and Pharmacy Practice Research and Innovation Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.; Clinical Trials and Evidence-Based Syntheses Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.
Phumart P; Health Services and Pharmacy Practice Research and Innovation Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.; Clinical Trials and Evidence-Based Syntheses Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.
Paktipat P; Social Pharmacy Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.; Health Services and Pharmacy Practice Research and Innovation Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.; Clinical Trials and Evidence-Based Syntheses Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, 44150, Thailand.
Babar ZU; Department of Pharmacy School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, UK.; Pokaż więcej
Źródło:: International journal of clinical pharmacy [Int J Clin Pharm] 2023 Dec; Vol. 45 (6), pp. 1326-1348. Date of Electronic Publication: 2023 May 26.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Pharmaceutical Services*
Humans ; Cost-Benefit Analysis ; Delivery of Health Care ; Canada ; Netherlands

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Netherlands"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Starter badań:

Netherlands.